brain
reninangiotensin
system
continu
enigmat
year
brain
first
recogn
site
action
angiotensin
ii
review
focus
enzymat
pathway
format
degrad
grow
number
activ
angiotensin
brain
brief
descript
nomenclatur
peptidas
involv
process
angiotensin
peptid
brain
given
primari
interest
array
enzym
degrad
radiolabel
angiotensin
receptor
bind
assay
pose
major
challeng
studi
brain
angiotensin
receptor
debat
whether
accur
determin
brain
angiotensin
receptor
bind
kinet
yet
made
quandari
face
investig
brain
angiotensin
receptor
need
protect
radioligand
metabol
alter
maintain
characterist
receptor
situ
tenet
review
yet
fulli
understand
bind
characterist
brain
angiotensin
receptor
extent
distribut
brain
inabl
fulli
protect
angiotensin
metabol
alter
equilibrium
bind
condit
attain
first
definit
demonstr
effect
angiotensin
ii
ang
ii
brain
cross
perfus
studi
bickerton
buckley
howev
effect
produc
bloodborn
ang
ii
later
recogn
mediat
circumventricular
organ
brain
outsid
bloodbrainbarri
subsequ
casual
observ
booth
reveal
ang
ii
act
within
brain
initi
interest
possibl
exist
brain
reninangiotensin
system
ra
year
later
ganten
et
al
report
exist
reninlik
activ
brain
research
brain
ra
began
earnest
influenc
brain
ra
hydrominer
balanc
arteri
blood
pressur
neurosecretori
function
overal
bodi
homeostasi
well
document
sever
excel
review
articl
cover
earli
studi
brain
ra
tradit
function
angiotensin
brain
establish
time
recognit
presenc
multipl
receptor
subtyp
angiotensin
brain
well
novel
function
metabolit
octaand
heptapeptid
angiotensin
greatli
extend
rang
activ
attribut
brain
ra
recent
review
cover
aspect
brain
ra
rate
synthesi
well
rate
degrad
neurotransmitt
neuromodul
import
factor
initi
termin
biolog
effect
principl
appli
peptid
hormon
well
regul
proteas
otherwis
call
peptidas
proteinas
proteolyt
enzym
gener
metabol
human
genom
encod
sever
hundr
proteas
function
mani
yet
determin
peptidas
involv
process
angiotensin
peptid
collect
term
angiotensinas
term
larg
use
infer
degrad
know
enzym
gener
activ
angiotensin
angiotensinas
compris
three
group
peptidas
amino
endoand
carboxypeptidas
aminopeptidas
tradit
view
import
group
account
angiotensinas
activ
variou
tissu
howev
known
angiotensin
peptid
process
broad
varieti
peptidas
format
primari
activ
angiotensin
ang
ii
consid
occur
via
cascad
enzymat
reaction
start
larg
protein
precursor
fact
enzym
renin
first
compon
ra
discov
led
name
hormon
system
reninangiotensin
system
howev
seen
renin
certainli
angiotensinform
enzym
howev
respect
discoveri
renin
tigerstedt
bergstrom
use
term
reninangiotensin
system
like
continu
section
primari
focu
format
ang
ii
ang
iii
angiotensinogen
ang
angiotensin
act
classic
receptor
format
activ
angiotensin
ang
ang
ii
ang
iii
act
receptor
pirmarili
address
section
known
substrat
renin
angiotensinogen
known
precursor
activ
octapeptid
angiotensin
ii
ang
ii
brain
primari
sourc
angiotensinogen
astroglia
report
constitut
secret
extracellular
fluid
brain
classic
pathway
ra
cleav
renin
ec
leu
leu
residu
yield
angiotensin
ang
fig
renin
aspartyl
peptidas
famili
brain
rodent
human
renin
express
two
form
one
secret
either
activ
renin
secretorystorag
granul
form
extracellularli
secret
inact
prorenin
form
recent
describ
nonsecret
brainspecif
intracellular
renin
comparison
secret
renin
express
much
higher
amount
brain
tissu
sever
peptidas
addit
renin
capabl
form
ang
angiotensinogen
among
acid
proteas
fig
pathway
format
angiotensin
peptid
brain
abbrevi
use
aceangiotensin
convert
enzym
homolog
angiotensin
convert
enzym
apaaminopeptidas
alapadipocyt
deriv
leucineaminopeptidas
lrapleukocytederiv
arginin
aminopeptidas
nepneutr
endopeptidas
topthimet
endopeptidas
proepprolylendopeptidas
procpprolylcarboxypeptidas
apxaminopeptidas
x
dapaspartyl
aminopeptidas
plapirapplacent
leucineaminopeptidaseinsulinregul
aminopeptidas
apnapmaminopeptidas
nm
apbaminopeptidas
b
dpp
idipeptidyl
peptidas
dpp
iiidipeptidyl
peptidas
iii
number
amino
acid
residu
fragment
base
number
angiotensinogen
larger
size
arrow
indic
classic
metabol
pathway
angiotensin
peptid
brain
cathepsin
e
ec
ec
aspart
proteinas
belong
famili
form
ang
angiotensinogen
substrat
fig
cathepsin
typic
lysosom
enzym
wherea
cathepsin
e
found
endoplasm
reticulum
endosom
cell
compart
enzym
involv
process
variou
peptid
precursor
two
neutral
peptidas
also
capabl
gener
ang
angiotensinogen
brain
elastas
proteinas
fig
furthermor
two
neutral
peptidasescathepsin
g
ec
tonin
togeth
elastas
proteinas
form
ang
ii
directli
angiotensinogen
without
ang
product
intermedi
cleav
peptid
bond
phe
residu
fig
cathepsin
g
tonin
elastas
proteinas
neutral
serin
proteinas
famili
local
mainli
endosom
lysosom
wide
express
differ
mammalian
tissu
includ
brain
essenti
part
cell
proteolyt
machineri
still
grow
list
known
physiolog
substrat
role
mani
biolog
process
classic
ra
cascad
decapeptid
ang
convert
ang
ii
angiotensinconvert
enzym
ace
kininas
ii
ec
ace
one
extens
studi
mammalian
peptidas
exist
solubl
membranebound
form
member
famili
zinc
metallopeptidas
ace
possess
dipeptidyl
carboxypeptidas
activ
select
convert
ang
ang
ii
desaspangiotensin
ang
iii
ang
ang
bradykinin
inact
metabolit
addit
metabol
sever
peptid
howev
ace
metabol
ang
ii
presum
due
inabl
metabol
pro
bond
solubl
form
ace
distribut
extracellularli
membranebound
form
extern
face
plasma
membran
thu
format
ang
ii
ang
ace
thought
occur
extracellularli
two
peptidasescathepsin
carboxypeptidas
lysosom
protect
protein
deamidas
ec
human
homologu
ace
aceh
remov
ang
gener
ang
ang
metabol
ang
ii
cathepsin
fig
cathepsin
multifunct
lysosom
acid
serin
carboxypeptidas
famili
also
function
protect
activ
protein
neuraminidas
betagalactosidas
cathepsin
also
act
esterasectermin
deamidas
neutral
ph
carboxypeptidas
esterasectermin
deamidas
function
fulli
separ
protect
function
like
ace
member
famili
zinc
metallopeptidas
exist
membranebound
form
wide
express
varieti
mammalian
tissu
includ
brain
contrast
ace
cleav
singl
ctermin
residu
peptid
substrat
includ
ang
ang
ii
ang
ang
anoth
differenti
featur
ace
unabl
cleav
bradykinin
hiphisleu
insensit
ace
inhibitor
eg
lisinopril
captopril
addit
role
carboxypeptidas
also
receptor
sever
acut
respiratori
syndrom
sar
coronaviru
elastas
proteinas
tonin
cathepsin
b
g
also
cleav
carboxi
termin
hisleu
ang
form
ang
ii
fig
manner
similar
wellcharacter
format
ang
ii
ace
cathepsin
b
member
cystein
cathepsin
famili
ubiquit
mammalian
lysosom
peptidas
express
brain
function
convert
sever
peptid
precursor
activ
peptid
chymas
anoth
enzym
capabl
form
ang
ii
ang
enzym
larg
associ
mast
cell
asid
pineal
gland
pituitari
littl
chymas
activ
brain
aminopeptidas
tradit
thought
inactiv
ang
ii
except
aminopeptidas
amedi
format
gener
shortliv
heptapeptid
ang
iii
desasp
desarg
ang
ii
hexapeptid
ang
iv
littl
activ
classic
ang
ii
receptor
mediat
pressor
dipsogen
salt
appetiteinduc
hormonereleas
effect
ang
ii
thu
consid
weak
agonist
best
howev
discoveri
high
affin
bind
site
ang
iv
brain
report
memori
enhanc
effect
ang
iv
yet
anoth
activ
angiotensin
discov
thu
aminopeptidas
newli
cast
angiotensinsynthes
enzym
addit
continu
role
angiotensin
inactiv
inde
suggest
aminopeptidas
activ
essenti
format
activ
angiotensin
peptid
brain
although
recent
studi
laboratori
challeng
hypothesi
one
known
accept
peptidas
respons
process
ang
ii
apa
glutamyl
aminopeptidas
ec
cleav
asp
ang
ii
gener
heptapeptid
ang
iii
ang
iii
also
gener
ang
without
ang
ii
product
intermedi
format
desasp
ang
ang
apa
aminopeptidas
x
see
also
section
subsequ
carboxypeptidas
cleavag
leuhi
ace
fig
apa
wide
express
mammalian
membranebound
aminopeptidas
member
famili
zinc
metallopeptidas
abundantli
express
brain
catalyt
domain
peptidas
ectodomain
protein
thu
posit
metabol
peptid
extracellular
milieu
specif
cleav
acid
residu
aspart
acid
glutam
acid
nterminu
peptid
substrat
predominantli
ang
ang
ii
anoth
aminopeptidas
cleav
asp
ang
ii
known
adipocytederiv
leucin
aminopeptidas
alap
puromycin
insensit
leucylspecif
aminopeptidas
pilsap
moreov
sequenti
cleav
ntermin
amino
acid
gener
angiotensin
hisproph
fig
alap
member
oxytocinas
subfamili
aminopeptidas
found
solubl
membranebound
form
extens
express
brain
mani
tissu
togeth
member
subfamili
placent
leucin
aminopeptidas
plap
cysteinyl
aminopeptidas
ec
ep
also
known
insulinregul
aminopeptidas
irap
ang
iv
receptor
leukocytederiv
arginin
aminopeptidas
lrap
play
import
role
mainten
homeostasi
pregnanc
memori
retent
blood
pressur
regul
antigen
present
aminopeptidas
x
amastatin
bestatinand
edtainsensit
aminopeptidas
activ
describ
sim
cowork
cleav
asp
ang
ang
ii
form
nonapeptid
fragment
ang
ang
iii
respect
enzym
like
aspartyl
aminopeptidas
dap
ec
first
describ
kelli
et
al
later
character
wilk
et
al
member
famili
metalloproteinas
dtt
ophenanthrolin
sensit
amastatin
bestatin
rel
edta
insensit
enzym
capabl
effici
metabol
ang
ii
ang
iii
note
desasp
ang
process
ang
iii
ace
fig
note
line
angiotensin
synthesi
degrad
blur
due
discoveri
physiolog
action
receptor
angiotensin
peptid
previous
consid
inact
metabolit
howev
consid
primari
action
ra
particular
effect
receptor
subtyp
mediat
nearli
physiolog
pathophysiolog
effect
ang
ii
anyth
less
carboxi
termin
heptapeptid
consid
inact
metabolit
histor
aminopeptidas
view
primari
metabol
enzym
degrad
ang
ii
howev
recogn
effect
peptidas
complex
apa
dap
strong
prefer
acid
amino
acid
consid
primari
enzym
respons
degrad
ang
ii
ang
iii
howev
sinc
ang
iii
thought
fulli
activ
agonist
receptor
metabol
step
hardli
consid
degrad
hand
ang
iii
appear
highli
labil
shortliv
process
format
ang
iii
could
consid
prelud
inactiv
peptid
least
agonist
interest
observ
ang
iv
bind
solubl
form
human
apa
slowli
metabol
therebi
act
competit
inhibitor
investig
also
report
small
amount
ang
iii
metabol
ang
iv
solubl
apa
addit
abil
form
ang
iii
ang
ii
report
abil
apx
like
dap
form
de
asp
ang
ang
suggest
result
format
physiolog
antagonist
angiotensin
receptor
subtyp
interest
infer
observ
ace
inhibitor
could
prolong
lifespan
endogen
receptor
antagonist
alap
describ
section
capabl
cleav
ntermin
amino
acid
start
ang
ii
tripeptid
hisproph
thu
capabl
metabol
angiotensin
complet
inact
peptid
fig
interestingli
close
relat
plapirap
lrap
abl
metabol
ang
ii
plapirap
report
metabol
ang
iii
iv
wherea
lrap
abil
metabol
ang
iii
tripeptid
hisproph
sequenti
elimin
ntermin
amino
acid
apn
ec
aminopeptidas
alanyl
aminopeptidas
apb
ec
arginyl
aminopeptidas
also
gener
consid
inactiv
enzym
form
angiotensin
fragment
neglig
affin
classic
ang
ii
receptor
cleav
arg
ang
iii
form
desasp
desarg
ang
ii
ang
iv
predominantli
involv
learn
memori
function
mediat
mainli
ang
iv
receptor
addit
abil
cleav
arg
ang
iii
form
ang
iv
apn
also
cleav
val
ang
iv
form
ang
fig
put
inact
angiotensin
fragment
apn
apb
member
famili
znmetallopeptidas
apn
predominantli
character
membranebound
peptidas
catalyt
site
extracellular
domain
apb
secret
membranebound
proteas
apn
apb
ubiquit
distribut
differ
tissu
mammalian
organ
includ
brain
apn
metabol
regulatori
peptid
remov
ntermin
amino
acid
prefer
toward
neutral
residu
apb
demonstr
strict
specif
arg
andor
ly
residu
n
terminu
variou
peptid
suggest
domin
role
apb
rather
apn
process
ang
iii
howev
suggest
apn
predomin
enzym
respons
brain
ang
iii
metabol
mous
rat
brain
besid
peptidas
activ
apn
also
shown
receptor
coronavirus
human
herpesviru
bacillu
thuringiensi
cryia
c
toxin
target
tissu
addit
apa
dap
alap
dipeptidyl
peptidas
dpp
ec
previous
call
cathepsin
c
j
dipeptidyl
peptidas
iii
dpp
iii
ec
also
respons
ntermin
amino
acid
cleavag
ang
ii
aminopeptidas
respons
process
variou
protein
peptid
includ
angiotensin
remov
asp
arg
dipeptid
ang
ii
form
ang
iv
fig
diaminopeptidas
also
report
cleav
valtyr
ang
iv
form
put
inact
ang
fragment
dpp
dpp
iii
first
character
acid
lysosom
basic
cytosol
cystein
peptidas
respect
howev
membraneassoci
form
also
describ
shown
tabl
dpp
iii
possess
substanti
higher
affin
ang
ii
apa
affin
dpp
iii
ang
iii
analog
similar
affin
apn
ang
iii
lead
suggest
dpp
iii
also
metabol
ang
iii
inact
ang
fragment
tabl
sever
endopeptidas
metabol
ang
ii
brain
neprilysin
thimet
oligopeptidas
neutral
endopeptidas
cleav
tyr
ile
bond
form
two
tetrapeptid
fig
prolyl
endopeptidas
also
metabol
ang
ii
cleav
ctermin
phe
ang
ii
form
ang
fig
moreov
endopeptidas
abl
cleav
ang
pro
phe
bond
form
ang
fig
observ
made
ang
could
stimul
vasopressin
releas
hypothalam
explant
remov
phe
ang
ii
thought
metabol
inactiv
peptid
howev
ang
wide
recogn
activ
right
receptor
may
play
role
hippocamp
plastic
thu
format
ang
prolyl
carboxypeptidas
must
view
enzymat
step
lead
format
activ
angiotensin
neutral
endopeptidas
ec
ep
neprilysin
nep
member
membranebound
famili
zincdepend
metalloproteas
cleav
peptid
bond
amino
acid
side
hydrophob
amino
acid
residu
constitut
express
sever
tissu
includ
brain
kidney
development
regul
cell
type
eg
lymphocyt
termin
activ
peptid
involv
cardiovascular
regul
inflammatori
phenomena
critic
synapt
neuropeptid
metabol
neutral
endopeptidas
call
cholinesteras
peptiderg
synaps
author
note
neutral
endopeptidas
report
cleav
ang
ang
ang
iii
ang
ang
ang
thimet
oligopeptidas
ec
ep
thimet
endopeptidas
pzpeptidas
endooligopeptidas
neurolysin
ec
ep
neurotensindegrad
enzym
member
famili
zndepend
metalloendopeptidas
ubiquit
distribut
central
nervou
system
peripher
organ
mammal
initi
proteas
consid
solubl
enzym
thimet
oligopeptidas
predominantli
nuclear
neurolysin
cytosol
later
demonstr
rat
brain
thimet
oligopeptidas
activ
associ
membran
includ
plasma
membran
endosom
synapt
vesicl
moreov
shivakumar
et
al
recent
show
thimet
oligopeptidas
associ
receptor
kidney
cell
plasma
membran
receptor
intern
suggest
possibl
mechan
endosom
disposit
ligand
could
facilit
receptor
recycl
case
neurolysin
shown
enzym
mainli
cytosol
astrocyt
larg
membraneassoci
neuron
despit
endopeptidas
prolyl
endopeptidas
prolyl
oligopeptidas
postprolin
cleav
enzym
member
prolyl
peptidas
subfamili
serin
proteas
cleav
proxaa
peptid
bond
xaa
amino
acid
even
xaa
amino
acid
omega
amino
acid
peptid
also
abil
form
ang
ang
ii
ang
ang
ang
iii
ang
ang
iv
prolyl
endopeptidas
intracellular
enzym
respons
degrad
sever
peptid
hormon
neuropeptid
highli
conserv
mammal
one
abundantli
express
brain
peptidas
cathepsin
b
elastas
describ
abil
form
ang
angiotensinogen
also
shown
abl
cleav
val
tyr
bond
ang
ii
wherea
cathepsin
g
cleav
tyr
ile
bond
fig
variou
fragment
form
endopeptidas
virtual
devoid
biolog
activ
note
cleav
leu
ang
phe
ang
ii
make
ang
ang
respect
thu
view
primarili
angiotensinform
enzym
interestingli
latter
two
peptid
seem
metabol
note
ang
substrat
ace
apn
dppiii
wherea
ang
metabol
ang
ii
cathepsin
describ
section
fig
prolyl
carboxypeptidas
ec
angiotensinas
c
peptidyl
prolylamino
acid
hydrolas
anoth
carboxypeptidas
capabl
cleav
ang
ii
ang
iii
proph
bond
yield
ang
ang
respect
fig
exist
membraneassoci
extracellular
form
remov
omega
amino
acid
peptid
penultim
amino
acid
prolin
acid
ph
optimum
ph
hydrolyz
short
synthet
peptid
substrat
retain
signific
activ
neutral
rang
longer
natur
occur
peptid
eg
ang
ii
ang
iii
desarg
bradykinin
discoveri
brain
ra
bind
site
angiotensin
peptid
brain
extens
studi
use
receptor
bind
techniqu
presenc
angiotensin
bind
site
brain
demonstr
varieti
speci
subsequ
vitro
autoradiograph
studi
directli
local
bind
site
specif
brain
nuclei
howev
begin
studi
face
major
pitfallsever
metabol
degrad
angiotensin
peptid
could
neg
influenc
correct
gener
interpret
bind
experi
two
major
problem
imposs
reach
steadyst
conditionsth
time
cours
bind
radiolabel
angiotensin
bell
shape
fig
identif
differ
angiotensin
fragment
along
intact
ligand
bound
specif
three
type
attempt
solv
problem
addit
proteas
inhibitor
incub
medium
use
purifi
plasma
membran
develop
peptidaseresist
analog
angiotensin
attempt
overcom
problem
metabol
degrad
angiotensin
ligand
receptor
bind
studi
invari
includ
varieti
proteas
inhibitor
common
includ
sulfhydryl
reagent
dithiothreitol
chelat
agent
edta
egta
ophenanthrolin
pure
proteas
inhibitor
leupeptin
pepstatin
bacitracin
amastatin
bestatin
pmsf
unrel
peptid
glucagon
insulin
bovin
serum
albumin
note
addit
peptidas
inhibitor
alway
help
protect
ligand
degrad
one
commonli
use
peptidas
inhibitor
angiotensin
receptor
bind
assay
bacitracin
report
activ
aspartyl
aminopeptidas
dap
would
promot
convers
ang
iii
thu
distort
observ
bind
kinet
moreov
dithiothreitol
dtt
disulfid
reduc
agent
capabl
activ
thimet
oligopeptidas
dppiii
virtual
brain
angiotensin
receptor
bind
assay
use
membran
fraction
case
involv
mechan
osmot
disrupt
cell
centrifug
precipit
membran
fraction
solublecytosol
enzym
well
microsom
membran
fraction
discard
supernat
occas
synaptosom
prepar
use
receptor
bind
assay
focu
receptor
express
extracellular
side
plasma
membran
howev
addit
step
must
taken
ensur
receptorligand
intern
receptormedi
endocytosi
alter
bind
kinet
lead
subsequ
degrad
receptorassoci
angiotensin
peptid
initi
studi
brain
angiotensin
receptor
use
iang
ii
howev
subsequ
studi
use
angiotensin
analog
modifi
posit
gave
much
better
result
fig
time
cours
specif
bind
iang
iii
rat
brain
membran
prepar
rat
brain
membran
mg
initi
wet
weightml
prepar
describ
previous
incub
medium
contain
standard
assay
buffer
mm
nacl
mm
edta
mm
bacitracin
mm
napo
ph
plu
follow
peptidas
inhibitor
ophenanthrolin
mm
puromycin
mm
phenylmethylsulfonyl
fluorid
mm
total
mg
initi
wet
weight
brain
membran
present
assay
carri
nonspecif
bind
determin
presenc
ang
ii
subtract
total
bind
deriv
specif
bind
common
amino
termin
substitut
sarcosin
nmethyl
glycin
aspart
acid
sarcosin
secondari
amin
resist
degrad
aminopeptidas
lack
sidechain
alpha
carbon
also
contribut
metabol
stabil
sinc
poor
substrat
acid
aminopeptidas
apa
dap
primarili
respons
remov
asp
ang
ii
common
substitut
carboxi
termin
introduct
alkyl
side
chaincontain
amino
acid
isoleucin
often
use
amino
acid
substitut
aromat
phenylalanin
aliphat
amino
acid
convert
peptid
antagonist
although
report
suggest
agonist
properti
peptid
retain
advantag
use
antagonist
angiotensin
peptid
primari
angiotensin
receptor
subtyp
g
proteincoupl
receptor
show
differ
agonist
bind
affin
state
depend
presenc
gtp
gdp
note
characterist
agonist
affin
shift
receptor
demonstr
receptor
show
shift
except
presenc
dithiothreitol
receptor
also
appear
intern
howev
consid
unnatur
sequenc
angiotensin
peptid
analog
may
fulli
repres
agonist
bind
angiotensin
receptor
although
abovement
approach
posit
impact
preserv
angiotensin
ligand
degrad
none
complet
success
metabol
degrad
still
continu
fig
moreov
grover
et
al
abhold
et
al
suggest
bind
assay
use
angiotensin
peptid
includ
measur
ligand
metabol
identif
specif
bound
radioact
correct
specif
bind
base
amount
authent
radioligand
bound
howev
consid
metabol
might
occur
postbind
case
radiolabel
metabolit
may
repres
portion
specif
bind
radioligand
hand
suggest
correct
specif
bind
base
observ
metabol
identif
specif
bound
radioact
technic
challeng
cumbersom
procedur
might
explain
pauciti
report
address
problem
ie
correct
specif
bind
base
observ
metabol
identif
specif
bound
radioact
fulli
determin
bind
characterist
angiotensin
ligand
brain
tissu
also
note
metabol
degrad
also
affect
abil
nonradiolabel
angiotensin
peptid
usual
term
cold
use
estim
nonspecif
bind
redioligand
fulli
compet
specif
bind
site
determin
affin
express
ic
k
valu
nonradiolabel
angiotensin
analog
bind
brain
angiotensin
receptor
also
differenti
affect
suscept
metabol
brain
peptidas
disappoint
outcom
practic
preserv
angiotensin
ligand
metabol
degrad
receptor
bind
assay
case
sulfhydryl
reduc
agent
particular
dtt
pioneer
studi
glossmann
et
al
bennett
snyder
indic
addit
dtt
requir
protect
angiotensin
radioligand
metabol
degrad
later
shown
dtt
abil
increas
bind
affin
ang
ii
brain
chang
densiti
bind
site
period
nearli
angiotensin
receptor
bind
studi
conduct
brain
carri
presenc
mm
dtt
printz
et
al
paper
mention
studi
laboratori
question
thiol
essenti
optimum
bind
ang
ii
membran
isol
brain
adren
howev
start
earli
studi
observ
ang
ii
bind
site
nonneuron
tissu
vasculatur
liver
anterior
pituitari
show
reduc
ang
ii
bind
presenc
dtt
consist
observ
report
elli
nuenk
enhanc
activ
pituitari
dpp
iii
convert
ang
ii
ang
iv
moreov
activ
thimet
oligopeptidas
dtt
also
well
document
mysteri
continu
late
time
sulfhydryl
reduc
agent
continu
wide
use
angiotensin
receptor
bind
assay
neuron
fig
metabol
fate
iang
ii
bound
rat
brain
membran
prepar
rat
brain
membran
prepar
describ
previous
incub
medium
contain
mm
nacl
mm
edta
mm
bacitracin
mm
napo
ph
total
mg
initi
wet
weight
brain
membran
present
assay
carri
min
one
hour
incub
membran
suspens
centrifug
supernat
discard
pellet
resuspend
hplc
mobil
phase
acetonitril
triethylamin
phosphat
mm
phosphat
ph
period
vortex
min
recentrifug
supernat
fiter
filter
appli
water
inc
column
elut
acetonitril
triethylamin
phosphat
mm
phosphat
ph
eluat
run
reversephas
c
column
mobil
phase
either
acetonitril
triethylamin
phosphat
mm
phosphat
ph
allow
better
resolut
smaller
fragment
acetonitril
triethylamin
phosphat
mm
phosphat
ph
flow
rate
mlmin
radiolabel
ang
ii
fragment
identifi
base
elut
time
radioiodin
standard
ang
ii
fragment
hplc
condit
fraction
column
eluat
collect
count
gamma
counter
peripher
tissu
discoveri
angiotensin
receptor
subtyp
led
revel
sulfhydryl
agent
sever
impair
bind
receptor
recogn
fact
sulfhydryl
reduc
agent
impair
bind
angiotensin
ligand
receptor
speth
cowork
paper
show
sulfhydryl
agentsensit
nonsensit
contain
nuclei
distribut
rat
brain
note
inescap
conclus
studi
howev
vast
major
ang
ii
receptor
bind
studi
brain
homogen
larg
number
vitro
receptor
autoradiograph
studi
carri
condit
effect
inhibit
bind
subtyp
today
known
thu
portion
receptor
character
respons
variou
clear
metabol
pathway
angiotensin
complex
still
much
learn
metabol
fate
variou
angiotensin
peptid
brain
rel
import
mani
pathway
unknown
due
uncertainti
relat
cellular
local
affin
angiotensin
peptid
catalyt
capac
express
level
brain
factor
affect
metabol
fate
angiotensin
includ
development
differ
enzym
express
presenc
activ
inhibitor
enzym
redox
state
brain
also
appar
claim
specif
variou
enzym
inhibitor
must
consid
light
expans
enzym
capabl
metabol
angiotensin
peptid
defin
enzym
inhibitor
specif
inhibitor
enzym
prepar
test
inappropri
ignor
possibl
untest
enzym
could
affect
exampl
enzym
inhibitor
interact
sulfhydryl
group
like
widespread
effect
larg
number
protein
enzym
note
receptor
anoth
interest
develop
observ
differ
angiotensin
peptid
oppos
action
eg
ang
ii
counteract
effect
ang
ang
complementari
action
eg
ang
ii
protect
effect
ang
iv
virtu
abil
inhibit
aminopeptidas
may
angiotensin
fragment
also
capabl
indirectli
interact
metabol
process
angiotensin
peptid
despit
year
research
brain
angiotensin
receptor
problem
metabol
degrad
angiotensin
ligand
brain
ang
ii
receptor
bind
studi
remain
unsolv
none
report
bind
studi
angiotensin
receptor
immun
challeng
radioligand
remain
intact
throughout
incub
period
bound
radioligand
may
repres
bind
initi
radioligand
condit
angiotensin
peptid
protect
metabol
compromis
abil
angiotensin
receptor
bind
angiotensin
correct
character
receptor
bind
kinet
angiotensin
peptid
carri
condit
peptid
ligand
well
receptor
preserv
metabol
degrad
least
steadi
state
condit
attain
howev
time
one
need
insur
abil
angiotensin
receptor
interact
ligand
impair
procedur
design
protect
ligand
integr
continu
studi
brain
angiotensin
receptor
laboratori
focus
resolv
problem
begin
show
success
howev
also
provid
unanticip
result
presenc
pchloromurcuribenzo
acid
pcmb
novel
bind
site
angiotensin
peptid
observ
brain
howev
pcmb
like
dtt
inhibit
ang
ii
bind
receptor
presum
alter
critic
cystein
residu
receptor
thu
necessari
continu
vigil
alter
angiotensin
receptor
behavior
develop
effect
inhibitor
peptidas
metabol
angiotensin
